Skip to main content
Scope Fluidics S.A. logo

Scope Fluidics S.A. — Investor Relations & Filings

Ticker · SCP ISIN · PLSCPFL00018 LEI · 259400EUNFX4E2BEHU15 WAR Professional, scientific and technical activities
Open in API
Filings indexed 510 across all filing types
Latest filing 2024-09-30 Interim / Quarterly Rep…
Country PL Poland
Listing WAR SCP

About Scope Fluidics S.A.

https://scopefluidics.com/

Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.

Recent filings

Filing Released Lang Actions
Sprawozdanie Zarządu z działalności Grupy Kapitałowej Scope Fluidics S.A. za okres sześciu miesięcy zakończony 30 czerwca 2024 roku
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report for a period shorter than a full fiscal year (specifically, a six-month period ending 30.06.2024). It contains detailed consolidated and standalone financial statements, including income statements, cash flow statements, and balance sheets, as well as management commentary on business projects and strategy. This fits the definition of an Interim/Quarterly Report (IR). H1 2024
2024-09-30 Polish
Skrócone półroczne skonsolidowane sprawozdanie finansowe Grupy Kapitałowej Scope Fluidics S.A. za okres od 1 stycznia do 30 czerwca 2024 roku
Interim / Quarterly Report Classification · 1% confidence The document contains detailed consolidated financial statements, including the Statement of Profit or Loss, Statement of Financial Position, and various explanatory notes for the period ending 30.06.2024. It is a comprehensive financial report for a period shorter than a full fiscal year (a half-year report), which fits the definition of an Interim/Quarterly Report (IR). H1 2024
2024-09-30 Polish
Skrócone półroczne jednostkowe sprawozdanie finansowe Scope Fluidics S.A. za okres od 1 stycznia do 30 czerwca 2024 roku
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report containing detailed financial statements (Statement of Profit or Loss, Statement of Financial Position, etc.) for the period ending 30.06.2024. It includes notes to the financial statements, management information, and accounting policies. Since it covers a period shorter than a full fiscal year (six months) and contains substantive financial data, it is classified as an Interim/Quarterly Report. H1 2024
2024-09-30 Polish
Zawarcie umowy z jednostką notyfikowaną na przeprowadzenie procesu certyfikacji IVDR Panelu UNI oraz Interpretera - Content (PL)
Regulatory Filings Classification · 1% confidence The document text is very short (1001 characters) and announces a specific corporate action: the signing of an agreement with a notified body to conduct a conformity assessment (certification process) for the BACTEROMIC system under the EU IVDR regulation. This is a specific operational update related to product certification/regulatory compliance, not a standard financial report (like 10-K, IR, ER) or a general management/board change. It is a specific regulatory/operational announcement. Since it details a specific step in a project (certification) and is not a standard financial filing, it fits best under the general 'Regulatory Filings' category (RNS) as a specific, non-standard announcement, or potentially a Legal/Regulatory update (LTR) if the focus was on a dispute, but here it is proactive compliance. Given the options, RNS serves as the best catch-all for specific, non-financial regulatory/operational news that doesn't fit elsewhere.
2024-09-23 Polish
Rozpoczęcie wstępnej oceny w ramach procesu certyfikacji panelu UNI oraz interpretera systemu BACTEROMIC - Content (PL)
Environmental & Social Information Classification · 1% confidence The document text is very short (1024 characters) and discusses an update regarding the preliminary assessment by a notified body for the IVDR certification process of the BACTEROMIC system. It references a previous current report ('raport bieżący nr 5/2024') and informs about the progress of a specific project milestone (certification readiness). This type of specific, non-standardized operational update, especially one referencing a prior 'raport bieżący' (current report) without being the full financial report (10-K, IR) or a standard earnings release (ER), fits best under the general regulatory announcement category, which is RNS (Regulatory Filings). It is not a standard AGM, DIRS, DIV, or ER announcement.
2024-09-04 Polish
Decyzja dotycząca panelu UNI systemu BACTEROMIC - Content (PL)
Regulatory Filings Classification · 1% confidence The document is written in Polish and references a 'raport bieżący nr 5/2024' (current report no. 5/2024). It discusses internal operational decisions regarding product development (Panel UNI, UNIMAX, PBC) and regulatory certification processes (IVDR) for a subsidiary, Bacteromic. This content relates to ongoing business operations, strategic updates, and regulatory compliance efforts, but it is not a formal financial report (like 10-K or IR), a dividend announcement, or a management change notice. Since it is a specific, non-standard operational update that doesn't fit the highly specific categories like ER, CT, or DIV, and it is a formal report update referencing previous reports, it best fits the general 'Regulatory Filings' category as a catch-all for significant, non-standard corporate disclosures, or potentially a general business update not covered elsewhere. Given the options, RNS (Regulatory Filings) is the most appropriate fallback for a specific, non-financial, operational regulatory update that isn't a standard financial release or management change.
2024-08-29 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.